ANGO Angiodynamics Inc
Price (delayed)
$9.52
Market cap
$386.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.01
Enterprise value
$341.82M
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include
Highlights
Angiodynamics's EPS has soared by 82% from the previous quarter and by 79% YoY
ANGO's net income has surged by 82% since the previous quarter and by 78% year-on-year
The quick ratio has decreased by 24% YoY but it has increased by 2.7% QoQ
Angiodynamics's equity has decreased by 15% YoY
The revenue has declined by 13% year-on-year
Key stats
What are the main financial stats of ANGO
Market
Valuations
Earnings
Shares outstanding
40.61M
Market cap
$386.58M
Enterprise value
$341.82M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.07
Price to sales (P/S)
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.21
Revenue
$283.32M
Gross profit
$154M
Operating income
-$48.93M
Net income
-$41.39M
EBIT
-$42.63M
EBITDA
-$13.86M
Free cash flow
-$33.83M
Per share
Balance sheet
Liquidity
EPS
-$1.01
EPS diluted
-$1.01
Free cash flow per share
-$0.83
Book value per share
$4.59
Revenue per share
$6.94
TBVPS
$5.25
Total assets
$285.42M
Total liabilities
$99.55M
Debt
$0
Equity
$185.87M
Working capital
$94.3M
Debt to equity
0
Current ratio
2.21
Quick ratio
1.13
Net debt/EBITDA
3.23
Margins
Efficiency
Dividend
EBITDA margin
-4.9%
Gross margin
54.4%
Net margin
-14.6%
Operating margin
-17.3%
Return on assets
-13.9%
Return on equity
-21.4%
Return on invested capital
-52.2%
Return on capital employed
-20.6%
Return on sales
-15%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANGO stock price
How has the Angiodynamics stock price performed over time
Intraday
0.63%
1 week
3.03%
1 month
-0.73%
1 year
50.39%
YTD
3.93%
QTD
1.38%
Financial performance
How have Angiodynamics's revenue and profit performed over time
Revenue
$283.32M
Gross profit
$154M
Operating income
-$48.93M
Net income
-$41.39M
Gross margin
54.4%
Net margin
-14.6%
ANGO's net income has surged by 82% since the previous quarter and by 78% year-on-year
The company's net margin has surged by 81% QoQ and by 75% YoY
ANGO's operating income has soared by 80% since the previous quarter and by 75% year-on-year
The company's operating margin has surged by 79% QoQ and by 72% YoY
Growth
What is Angiodynamics's growth rate over time
Valuation
What is Angiodynamics stock price valuation
P/E
N/A
P/B
2.07
P/S
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.21
Angiodynamics's EPS has soared by 82% from the previous quarter and by 79% YoY
The P/B is 38% more than the 5-year quarterly average of 1.5 and 29% more than the last 4 quarters average of 1.6
Angiodynamics's equity has decreased by 15% YoY
The P/S is 25% more than the last 4 quarters average of 1.1 but 24% less than the 5-year quarterly average of 1.8
The revenue has declined by 13% year-on-year
Efficiency
How efficient is Angiodynamics business performance
ANGO's ROIC has soared by 83% QoQ and by 69% YoY
Angiodynamics's ROS has soared by 82% from the previous quarter and by 76% YoY
ANGO's ROA has soared by 81% since the previous quarter and by 67% year-on-year
The ROE has soared by 81% since the previous quarter and by 60% year-on-year
Dividends
What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANGO.
Financial health
How did Angiodynamics financials performed over time
Angiodynamics's total assets is 187% higher than its total liabilities
The quick ratio has decreased by 24% YoY but it has increased by 2.7% QoQ
ANGO's current ratio is up by 12% since the previous quarter but it is down by 3.5% year-on-year
The company's debt is 100% lower than its equity
Angiodynamics's equity has decreased by 15% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.